SLGL

Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)

About Sol-Gel Technologies Ltd. - Ordinary Shares (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high

$66.50

Daily low

$63.00

Price at open

$66.00

52 Week High

$97.97

52 Week Low

$28.81

Market cap

206.3M

Dividend yield

Volume

9,430

Avg. volume

38,995

P/E ratio

-11.16

Sol-Gel Technologies Ltd. - Ordinary Shares News